# Delineation of Novel Monogenic Disorders in the United Arab Emirates Population

> **NCT03589079** · — · UNKNOWN · sponsor: **Imperial College London Diabetes Centre** · enrollment: 150 (estimated)

## Conditions studied

- Mendelian Disorders
- Genetic Disorder
- Novel Mutation
- Hereditary Disorder
- De Novo Mutation
- Inherited Disease
- Single-Gene Defects

## Interventions

- **GENETIC:** Sanger and/or Next Generation Sequencing (NGS)

## Key facts

- **NCT ID:** NCT03589079
- **Lead sponsor:** Imperial College London Diabetes Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2021-01
- **Final completion:** 2021-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2020-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03589079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03589079, "Delineation of Novel Monogenic Disorders in the United Arab Emirates Population". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03589079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*